MedTrace Logo

Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh

NCT05520034 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2025-09-15

No results posted yet for this study

Summary

Stroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and lifestyle changes. Nurse-led health education with (self) monitoring of modifiable risk factors and behaviors can be an effective way to create knowledge about the behavioral changes in stroke patients.

The investigators hypothesized that health education among first stroke patients and their family caregivers could reduce the stroke recurrence rate by controlling modifiable risk factors compared to the first stroke patients without health education.

Conditions

Interventions

BEHAVIORAL

Health Education

The participants received a 45mins, face-to-face group health education after enrollment and during the 6th month by a RA nurse. Participants received the same health education over the phone call if the patient and family caregiver could not come for any reason. They also received a digital BP machine, a salt-measurement spoon, a medication box, and a recording notebook for monitoring. The intervention group receives health education above and reminder telephone calls provided by research assistant nurses every month (1st month to 3rd month: twice a month, and 4th month to 12th month: once a month)

Sponsors & Collaborators

  • National Institute of Neuro Sciences & Hospital, Bangladesh

    collaborator OTHER_GOV

  • Hiroshima University

    lead OTHER

Principal Investigators

  • KATM Ehsanul Huq, PhD · Hiroshima University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-02
Primary Completion
2024-02-28
Completion
2026-03-30

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520034 on ClinicalTrials.gov